First AD

Second AD

Briefly comment on the role of combination venetoclax-ibrutinib in this setting and available supporting data (high level). 

Progression on BTK Inhibitors: Treatment Options and Considerations 

Video content above is prompted by the following:

Briefly comment on the role of combination venetoclax-ibrutinib in this setting and available supporting data (high level).

Hillmen P. et al. J Clin Oncol. 2019;37(30):2722-2729

Kater AP, et al. Lancet Oncol. 2022;23(6):818-828

What is the potential role for venetoclax in combination with 2

Briefly review recent ESMO guideline updates for managing 

patients with R/R CLL who experience disease progression on a BTKi. 

How does your treatment approach differ for patients who progress on first-line BTK inhibitor therapy versus those who are intolerant to it?

When would you opt for an alternative BTKi vs changing to a venetoclax-based regimen?

Video Series

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Chronic Lymphocytic Leukemia

 Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy. 

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


ASH 2024: Global Updates in the Management of Chronic Lymphocytic Leukemia  

Peer Exchange

Panelists comment on the role of combination venetoclax-ibrutinib in this setting and available supporting data.